Published in Clin Colorectal Cancer on July 12, 2011
MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer (2012) 2.78
CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res (2012) 2.57
Identification and pathway analysis of microRNAs with no previous involvement in breast cancer. PLoS One (2012) 1.57
The role of microRNAs in colorectal cancer. Cancer J (2012) 1.44
Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med (2012) 1.34
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. Radiat Oncol (2012) 1.16
Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene (2012) 1.15
MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Manag Res (2014) 1.05
The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review. J Cancer (2013) 1.05
Distribution of miRNA expression across human tissues. Nucleic Acids Res (2016) 1.04
Prognostic significance of miR-194 in endometrial cancer. Biomark Res (2013) 1.01
MicroRNAs in colorectal cancer as markers and targets: Recent advances. World J Gastroenterol (2014) 0.98
MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget (2016) 0.94
MicroRNAs as promising biomarkers in cancer diagnostics. Biomark Res (2014) 0.92
Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet (2011) 0.88
miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma. Oncotarget (2015) 0.88
An update on microRNAs as colorectal cancer biomarkers: where are we and what's next? Expert Rev Mol Diagn (2014) 0.87
MicroRNA profiling of carcinogen-induced rat colon tumors and the influence of dietary spinach. Mol Nutr Food Res (2012) 0.87
Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget (2015) 0.86
Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy. Med Hypotheses (2013) 0.86
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer. Gynecol Oncol (2012) 0.83
Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis. Expert Rev Mol Diagn (2014) 0.83
A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer. Mol Cancer (2015) 0.81
MicroRNA transcriptome in swine small intestine during weaning stress. PLoS One (2013) 0.81
Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim. Int J Clin Exp Pathol (2015) 0.80
Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells. J Zhejiang Univ Sci B (2013) 0.78
Deep sequencing, profiling and detailed annotation of microRNAs in Takifugu rubripes. BMC Genomics (2015) 0.78
microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5. Stem Cell Res Ther (2016) 0.78
Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression. Sci Rep (2016) 0.77
Reduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemia. Jpn J Clin Oncol (2016) 0.77
miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer. Oncol Lett (2015) 0.77
The expanding regulatory universe of p53 in gastrointestinal cancer. F1000Res (2016) 0.75
The cluster microRNAs miR-194 and miR-215 suppress the tumorigenicity of intestinal tumor organoids. Cancer Sci (2017) 0.75
MicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer. Am J Transl Res (2017) 0.75
MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Dis Model Mech (2017) 0.75
miR-215 suppresses proliferation and migration of non-small cell lung cancer cells. Oncol Lett (2017) 0.75
Expression analysis of microRNA as prognostic biomarkers in colorectal cancer. Oncotarget (2016) 0.75
MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1. Oncol Lett (2017) 0.75
MicroRNAs as Biomarkers in Colorectal Cancer. Cancers (Basel) (2017) 0.75
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell (1993) 33.79
bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell (2003) 22.14
A microRNA component of the p53 tumour suppressor network. Nature (2007) 19.25
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res (2005) 18.58
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell (2007) 14.58
Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst (2004) 10.61
The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res (2007) 9.32
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res (2008) 7.45
Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle (2007) 7.00
MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer (2006) 5.37
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA (2007) 5.35
MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res (2007) 4.95
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res (2008) 3.58
The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res (2007) 2.92
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res (2006) 2.72
Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci U S A (1991) 2.67
CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J Biol Chem (2008) 2.63
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene (2009) 2.49
Intrinsic negative cell cycle regulation provided by PIP box- and Cul4Cdt2-mediated destruction of E2f1 during S phase. Dev Cell (2008) 2.40
L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle (2006) 2.37
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun (2008) 2.08
DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint. Genes Dev (2006) 1.96
miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res (2008) 1.87
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol Cancer (2010) 1.77
Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward? Cancer Biol Ther (2008) 1.74
L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes. Cell Cycle (2006) 1.53
Regulation of translation initiation following stress. Oncogene (1999) 1.51
Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim Biophys Acta (2006) 1.44
Translational regulation of human p53 gene expression. EMBO J (1996) 1.41
Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex. Mol Cell Biol (1999) 1.40
Regulation of p53 expression by thymidylate synthase. Proc Natl Acad Sci U S A (1999) 1.37
ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Mod Pathol (2008) 1.32
Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma. Cell Cycle (2006) 1.31
Small RNAs guide hematopoietic cell differentiation and function. J Immunol (2010) 1.24
Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1. Cell Death Differ (2009) 1.16
Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer. Clin Cancer Res (2010) 1.14
Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence. Cancer Res (2009) 1.10
Simultaneous gene expression analysis of steady-state and actively translated mRNA populations from osteosarcoma MG-63 cells in response to IL-1alpha via an open expression analysis platform. Nucleic Acids Res (2003) 0.99
Small RNAs in mammalian germline: Tiny for immortal. Differentiation (2010) 0.94
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA (2007) 5.35
Central nervous system damage due to acute paraquat poisoning: a neuroimaging study with 3.0 T MRI. Neurotoxicology (2012) 3.27
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics (2008) 3.11
The layered structure of human mitochondrial DNA nucleoids. J Biol Chem (2007) 2.74
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res (2006) 2.72
Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights (2006) 2.35
Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics Proteomics (2006) 1.94
miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res (2008) 1.87
Spatial distribution of soil heavy metal pollution estimated by different interpolation methods: accuracy and uncertainty analysis. Chemosphere (2010) 1.84
4,4',5,5'-Tetra-phenyl-3,3'-[methyl-idene-bis(sulfanedi-yl)]bis-(4H-1,2,4-triazole). Acta Crystallogr Sect E Struct Rep Online (2010) 1.81
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol Cancer (2010) 1.77
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer (2011) 1.59
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. PLoS One (2011) 1.49
In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc (2012) 1.48
Specific management of acute renal failure caused by an upper ureteral stone in a solitary pelvic kidney. Urol Res (2010) 1.40
MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS One (2009) 1.40
Platelet-derived growth factor-BB increases expression of connexin 43 in an extracellular-regulated protein kinase-dependent manner in bladder smooth muscle cells. Int J Urol (2012) 1.40
Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp Cell Res (2008) 1.33
Competitive binding of postsynaptic density 95 and Ca2+-calmodulin dependent protein kinase II to N-methyl-D-aspartate receptor subunit 2B in rat brain. Acta Pharmacol Sin (2004) 1.28
Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res (2010) 1.26
Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Cancer Genomics Proteomics (2009) 1.26
Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Int J Cancer (2009) 1.25
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res (2008) 1.24
Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Clin Cancer Res (2007) 1.23
Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci (2011) 1.23
Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. Hum Mol Genet (2013) 1.17
PKA phosphorylation couples hepatic inositol-requiring enzyme 1alpha to glucagon signaling in glucose metabolism. Proc Natl Acad Sci U S A (2011) 1.17
MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett (2012) 1.16
Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft. Urol Oncol (2011) 1.14
Prognostic significance of miR-205 in endometrial cancer. PLoS One (2012) 1.10
Synthesis and evaluation of macrocyclic gadolinium chelates as hepatospecific MRI agents. Acad Radiol (2002) 1.10
Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol (2013) 1.09
Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clin Colorectal Cancer (2013) 1.08
Detection of nanobacteria infection in type III prostatitis. Urology (2008) 1.06
Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett (2012) 1.05
Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res (2007) 1.05
Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide. Clin Cancer Res (2009) 1.04
Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis. Expert Rev Mol Med (2010) 1.04
MicroRNA: a third dimension in autophagy. Cell Cycle (2012) 1.04
Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis. Neurology (2013) 1.02
New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells. Mol Cancer (2010) 1.01
Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. PLoS One (2011) 1.01
A personalized microRNA microarray normalization method using a logistic regression model. Bioinformatics (2009) 1.01
Prognostic significance of miR-194 in endometrial cancer. Biomark Res (2013) 1.01
CDH11 expression is associated with survival in patients with osteosarcoma. Cancer Genomics Proteomics (2008) 1.00
The association of GSK3 beta with E2F1 facilitates nerve growth factor-induced neural cell differentiation. J Biol Chem (2008) 1.00
Suppression of CX43 expression by miR-20a in the progression of human prostate cancer. Cancer Biol Ther (2012) 0.99
Grey leaves in an alpine plant: a cryptic colouration to avoid attack? New Phytol (2014) 0.97
Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Mol Cancer Ther (2006) 0.97
Investigation of miRNA biology by bioinformatic tools and impact of miRNAs in colorectal cancer--regulatory relationship of c-Myc and p53 with miRNAs. Cancer Inform (2007) 0.96
Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells. Clin Cancer Res (2007) 0.96
Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin. J Cell Mol Med (2009) 0.95
Altered expression of calcium-activated K and Cl channels in detrusor overactivity of rats with partial bladder outlet obstruction. BJU Int (2008) 0.95
Changes of gap junctional cell-cell communication in overactive detrusor in rats. Am J Physiol Cell Physiol (2007) 0.95
Transurethral endoscopy technique with a ureteroscope for diagnosis and management of seminal tracts disorders: a new approach. J Endourol (2008) 0.94
A power-free microfluidic chip for SNP genotyping using graphene oxide and a DNA intercalating dye. Chem Commun (Camb) (2013) 0.93
Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. BMC Genomics (2006) 0.93
MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1. Brain Res Bull (2012) 0.93
Reconstitution of phycobilisome core-membrane linker, LCM, by autocatalytic chromophore binding to ApcE. Biochim Biophys Acta (2005) 0.93
Trichodermone, a spiro-cytochalasan with a tetracyclic nucleus (7/5/6/5) skeleton from the plant endophytic fungus Trichoderma gamsii. J Nat Prod (2014) 0.93
The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth. Biochim Biophys Acta (2012) 0.93
COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer. Int J Mol Med (2013) 0.92
N-methyl-D-aspartate receptor and L-type voltage-gated Ca2+ channel activation mediate proline-rich tyrosine kinase 2 phosphorylation during cerebral ischemia in rats. Neurosci Lett (2004) 0.92
Efficacy of endoscopic therapy for gastrointestinal bleeding from Dieulafoy's lesion. World J Gastroenterol (2011) 0.91
Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk. Int J Med Sci (2012) 0.91
Novel 2-substituted nitronyl nitroxides as free radical scavengers: synthesis, biological evaluation and structure-activity relationship. Bioorg Med Chem (2006) 0.91
Stereotactic localisation system: a modified puncture technique for percutaneous nephrolithotomy. Urol Res (2011) 0.91
Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer. Oncol Rep (2008) 0.90
Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer. Carcinogenesis (2013) 0.90
Loss of ryanodine receptor calcium-release channel expression associated with overactive urinary bladder smooth muscle contractions in a detrusor instability model. BJU Int (2005) 0.90
[Spatial distribution patterns and associations of Pinus koraiensis and Tilia amurensis in broad-leaved Korean pine mixed forest in Changbai Mountains]. Ying Yong Sheng Tai Xue Bao (2007) 0.89
Translational control analysis by translationally active RNA capture/microarray analysis (TrIP-Chip). Nucleic Acids Res (2010) 0.89
Diagnosis of male posterior urethral stricture: comparison of 64-MDCT urethrography vs. standard urethrography. Abdom Imaging (2011) 0.89
The impact of genomics in understanding human melanoma progression and metastasis. Cancer Control (2008) 0.89
Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking. PLoS One (2012) 0.89
Clinical evaluation of double-pigtail stent in patients with upper urinary tract diseases: report of 2685 cases. J Endourol (2008) 0.89
Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey. Chin Med J (Engl) (2008) 0.89
Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line. Cancer Genomics Proteomics (2009) 0.88
Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet (2011) 0.88
Enhancing detection of bladder carcinoma in situ by 3-dimensional optical coherence tomography. J Urol (2010) 0.88
Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma. Cancer Cytopathol (2012) 0.88
XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome. J Urol (2010) 0.88
Nonenzymatic chromophore attachment in biliproteins: conformational control by the detergent Triton X-100. Biochim Biophys Acta (2004) 0.87
Antibacterial activity of the lipopetides produced by Bacillus amyloliquefaciens M1 against multidrug-resistant Vibrio spp. isolated from diseased marine animals. Appl Microbiol Biotechnol (2013) 0.87
Cav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol (2006) 0.87
The effects of the c-kit blocker glivec on the contractile response of urinary bladder. J Surg Res (2011) 0.87
Roles of stem cell factor on loss of interstitial cells of Cajal in bladder of diabetic rats. Urology (2011) 0.87
Changes in T-type calcium channel and its subtypes in overactive detrusor of the rats with partial bladder outflow obstruction. Neurourol Urodyn (2007) 0.87
Integration and excision of a newly discovered bacteroides conjugative transposon, CTnBST. J Bacteriol (2006) 0.87
Comparing spatio-temporal clusters of arthropod-borne infections using administrative medical claims and state reported surveillance data. Spat Spatiotemporal Epidemiol (2012) 0.87
Bioconjugated lanthanide luminescent helicates as multilabels for lab-on-a-chip detection of cancer biomarkers. Analyst (2009) 0.86
Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment. Int Urogynecol J (2009) 0.86
A versatile ditopic ligand system for sensitizing the luminescence of bimetallic lanthanide bio-imaging probes. Chemistry (2008) 0.86
On-chip immunoassay using electrostatic assembly of streptavidin-coated bead micropatterns. Anal Chem (2009) 0.86
A frequent somatic mutation in CD274 3'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding. Hum Mutat (2012) 0.86